Graham Capital Management’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$407K Buy
+45,222
New +$714K 0.01% 699
2025
Q1
Sell
-11,726
Closed -$201K 1263
2024
Q4
$201K Buy
+11,726
New +$221K 0.01% 1080
2024
Q3
Sell
-13,544
Closed -$151K 1072
2024
Q2
$151K Sell
13,544
-17,730
-57% -$149K 0.01% 895
2024
Q1
$206K Sell
31,274
-6,361
-17% -$34.8K 0.01% 890
2023
Q4
$170K Buy
37,635
+9,430
+33% +$34.9K 0.01% 861
2023
Q3
$101K Sell
28,205
-10,727
-28% -$41.3K ﹤0.01% 937
2023
Q2
$144K Buy
+38,932
New +$144K ﹤0.01% 861
2022
Q2
Sell
-185,654
Closed -$339K 978
2022
Q1
$339K Buy
+185,654
New +$290K 0.02% 697

Other funds holding ADMA